Winton Group’s Sharps Compliance Corp SMED Stock Holding History

Winton Group’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,752	Closed	-$139K	–	1519
2021 Q3	$139K	Buy	+16,752	New	+$156K	0.01%	1275

Other funds holding SMED

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Winton Group's SMED Position: Q4 2021 in Review

Winton Group sold out of Sharps Compliance Corp (SMED) in Q4 2021, closing a stake of 16,752 shares — an estimated $139K sold.

Winton Group first reported a position in SMED in Q3 2021 and held it in 1 quarter. The position peaked at $139K in Q3 2021. 79 funds tracked by Wall St. Rank hold SMED as of Q4 2021.

Winton Group reported no remaining Sharps Compliance Corp position as of Q4 2021 after selling out during the quarter.
Winton Group sold 16,752 Sharps Compliance Corp shares in Q4 2021, an estimated $139K.
Winton Group first reported a position in Sharps Compliance Corp in Q3 2021 and held it in 1 quarter.
Winton Group's Sharps Compliance Corp position peaked at $139K in Q3 2021.
79 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.